This Act, referred to in subsecs. (a), (b), (e)(1), and (h), is Pub. L. 111–375, Jan. 4, 2011, 124 Stat. 4100, known as the National Alzheimer’s Project Act, which enacted this subchapter and provisions set out as a note under section 11201 of this title. For complete classification of this Act to the Code, see Short Title of 2010 Amendment note set out under section 11201 of this title and Tables.

Section was enacted as part of the National Alzheimer’s Project Act, and not as part of the Alzheimer’s Disease and Related Dementias Research Act of 1992 which comprises this chapter.

2024—Subsec. (c)(2). Pub. L. 118–92, § 2(1)(A), substituted “on, and coordination of,” for “and coordination of”.

Subsec. (c)(4). Pub. L. 118–92, § 2(1)(B), added subpar. (A) and redesignated former subpars. (A) and (B) as (B) and (C), respectively.

Subsec. (c)(5). Pub. L. 118–92, § 2(1)(C), inserted “and other underserved populations, including individuals with developmental disabilities such as Down syndrome,” after “populations” and substituted semicolon at end for “; and”.

Subsec. (c)(6), (7). Pub. L. 118–92, § 2(1)(D), (E), added par. (6) and redesignated former par. (6) as (7).

Subsec. (d)(2). Pub. L. 118–92, § 2(2), inserted “, across public and private sectors,” after “Nation’s progress” and “, including consideration of public-private collaborations, as appropriate” before period at end.

Subsec. (e)(2)(A)(xi) to (xiv). Pub. L. 118–92, § 2(3)(A)(i), added cls. (xi) to (xiv).

Subsec. (e)(2)(B). Pub. L. 118–92, § 2(3)(A)(ii)(I), substituted “15” for “12” in introductory provisions.

Subsec. (e)(2)(B)(v). Pub. L. 118–92, § 2(3)(A)(ii)(II), substituted “3 researchers” for “2 researchers” and “, including at least one researcher with demonstrated experience in recruitment and retention of underrepresented groups into research or clinical trials related to dementia;” for “; and”.

Subsec. (e)(2)(B)(vii), (viii). Pub. L. 118–92, § 2(3)(A)(ii)(III), (IV), added cls. (vii) and (viii).

Subsec. (e)(5)(A). Pub. L. 118–92, § 2(3)(B)(i), substituted “annual evaluations” for “an initial evaluation” and “research, risk reduction, public health, clinical” for “research, clinical”.

Subsec. (e)(5)(B). Pub. L. 118–92, § 2(3)(B)(ii), struck out “initial” before “recommendations”.

Subsec. (e)(5)(C). Pub. L. 118–92, § 2(3)(B)(iii)(I), struck out “initial” before “recommendations” in introductory provisions.

Subsec. (e)(5)(C)(ii). Pub. L. 118–92, § 2(3)(B)(iii)(II), inserted “and reduce disparities” before the semicolon.

Subsec. (e)(5)(D). Pub. L. 118–92, § 2(3)(B)(iv), substituted “annual evaluations” for “annually thereafter, an evaluation”.

Subsec. (e)(6). Pub. L. 118–92, § 2(3)(C), substituted “2035” for “2025”.

Subsec. (g)(1). Pub. L. 118–92, § 2(4)(A), substituted “that includes—” for “that includes”, designated remainder of existing provisions as subpar. (A), inserted semicolon after “an evaluation” and “and” after “their outcomes;”, and added subpar. (B).

Subsec. (g)(3)(A)(ii). Pub. L. 118–92, § 2(4)(B), inserted “and reduce disparities” before the semicolon.

Subsec. (h). Pub. L. 118–93, § 2(2), added subsec. (h). Former subsec. (h) redesignated (i).

Pub. L. 118–92, § 2(5), substituted “2035” for “2025”.

Subsec. (i). Pub. L. 118–93, § 2(1), redesignated subsec. (h) as (i).

Pub. L. 113–235, div. G, title II, § 230, Dec. 16, 2014, 128 Stat. 2492, provided that: “Hereafter, for each fiscal year through fiscal year 2025, the Director of the National Institutes of Health shall prepare and submit directly to the President for review and transmittal to Congress, after reasonable opportunity for comment, but without change, by the Secretary of Health and Human Services and the Advisory Council on Alzheimer’s Research, Care, and Services, an annual budget estimate (including an estimate of the number and type of personnel needs for the Institutes) for the initiatives of the National Institutes of Health pursuant to the National Alzheimer’s Plan, as required under section 2(d)(2) of Public Law 111–375 [42 U.S.C. 11225(d)(2)].”